They both contain the active ingredient semaglutide, but Wegovys maximum dose [2.4 mg] is higher and Wegovy comes in a single-use injectable pen, Antoni Adamrovich, nurse practitioner and co-owner of weight loss clinic TB2.Health, told Drugwatch
LX4211 increases serum glucagon-like peptide 1 and peptide YY levels by reducing sodium/glucose cotransporter 1 (SGLT1)-mediated absorption of intestinal glucose
Podgorny OV, Gulyaeva NV (2021) Glucocorticoid-mediated mechanisms of hippocampal damage: Contribution of subgranular neurogenesis
The before and after results people share online typically reflect months of use at therapeutic doses, not the starting dose period
In a Bank of America note published on Monday, the analyst argues that brand mail pharmacy margins can be 5-10% (and in many cases pharmacies are losing money on GLP-1 scripts), which are significantly lower than the 50% gross margins we estimate HIMS is capturing in its GLP-1 portfolio. It is unlikely that HIMS will follow Ros lead to partner with brand manufacturers, the analyst added, because HIMS differentiation and success is tied to its own brand equity for its products and selling branded pharmaceutical drugs would both hurt margins and cannibalize its core products. Diversifying Beyond the Major GLP-1 Drugs Hims could also look to broaden its weight loss offerings, leveraging its established telehealth platform to incorporate non-drug-based solutions
The MAD evaluated doses ranging from 140 mg to 420 mg administered every 4 weeks on days 1, 29 and 57
